Trials / Conditions / Secondary Lymphedema

Secondary Lymphedema

14 registered clinical trials studyying Secondary Lymphedema — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Enrolling By Invitation	Late Side-effects After Cervical Cancer Treatment - Prevention and Treatment NCT06786091	St. Olavs Hospital	N/A
Active Not Recruiting	Lymphaticovenous Anastomosis as Treatment for Lymphedema NCT05441943	Odense University Hospital	N/A
Completed	Study to Evaluate the Safety and Effectiveness of Dayspring for Lower Extremity Lymphedema NCT04897035	Koya Medical, Inc.	N/A
Completed	Proof-of-concept Study of LymphMonitor 1.0 to Assess the Lymphatic Vessel Function NCT04393168	Nicole Lindenblatt	Phase 1
Completed	Complete Decongestive Therapy on Head and Neck Lymphedema NCT04045860	Our Lady of the Lake Hospital	N/A
Completed	Imaging Biomarkers of Lymphatic Dysfunction NCT03760744	Vanderbilt University Medical Center	N/A
Completed	Complete Decongestive Therapy With Negative Pressure for Lipedema and Lymphedema Therapy NCT03634462	Vanderbilt University Medical Center	N/A
Unknown	Lymphatic Function in Patients Who Have Undergone Breast Cancer Treatment NCT03572998	University of Aarhus	N/A
Completed	Clinical Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema (AdeLE) NCT03658967	Herantis Pharma Plc.	Phase 2
Completed	Feasibility of Lymph Edema-induced Reticulation Subtraction Based on Computerized Tomography NCT03523494	Ulsan University Hospital	—
Unknown	Hyperbaric Oxygen Therapy to Reduce Lymphedema After Breast Cancer -an Explorative Clinical Trial NCT02895724	Danish Cancer Society	Phase 2
Terminated	A Phase I Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema NCT02994771	Herantis Pharma Plc.	Phase 1
Unknown	Supermicrosurgery for Breast Cancer Survivors With Lymphedema. NCT03578380	Sykehuset Telemark	N/A
Completed	Physical Therapies in the Decongestive Treatment of Lymphedema NCT01748604	Isabel Forner-Cordero, MD, PhD.	N/A